Cost-benefit analysis of lipid lowering therapy.
Jönsson
B
B
Johannesson
M
M
D003362:Cost-Benefit Analysis; D016903:Drug Monitoring / Q000191:economics; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000191:economics* / Q000401:mortality; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D008148:Lovastatin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D019821:Simvastatin; D015996:Survival Rate
D000960:Hypolipidemic Agents; D008148:Lovastatin; D019821:Simvastatin